1. Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists

2. dopamine多巴胺 norepinephrine去甲肾上腺素 epinephrine肾上腺素 Catechol

3. Structure-activity relationship of catecholamines and related compounds Substitution on the aromatic nucleus Substitution on the aromatic nucleus COMT, central activity COMT, central activity Substitution on the  -carbon atom Substitution on the  -carbon atom MAO, uptake-1, NE release MAO, uptake-1, NE release Substitution on the amino group Substitution on the amino group sensitivity to the subunits of receptors sensitivity to the subunits of receptors

5. Metabolism of catecholamines

6. Overview of catecholamines

7. Effect patterns of sympathomimetics

8. Subtypes of adrenoceptors

9. Effects of catecholamines （ therapeutic doses ）

10. Effects of catacholamines and non- catecholamines

11. BP  antagonist  antagonist epinephrine Epinephrine reversal （ adrenaline reversal ） epinephrine

12. 1. ,  receptor agonists Epinephrine 肾上腺素, Adrenaline

13. 1. ,  receptor agonists §1.1 Pharmacological effects §(1) Cardiac effects §  1 : HR , output , § oxygen consumption , inducing arrhythmia §(2) Vascular effects §  1 ： vasoconstriction, especially at larger doses §  2 ： vasodilatation of skeletal muscles and coronary vessels

14. §(3) Blood pressure § SP , DP  (at therapeutic doses) §(4) Bronchodilatation §  2 ： dilatation of bronchial smooth muscles §  1 ： reducing congestion and edema of bronchial mucosa §(5) Metabolic effects § blood glucose  ; free fatty acids  1. ,  receptor agonists

15. §1.2 Clinical uses §(1) Cardiac arrest §(2) Anaphylactic shock §(3) Acute bronchial asthma §(4) Local uses adjuvant for local anesthetics; control of bleeding § adjuvant for local anesthetics; control of bleeding 1. ,  receptor agonists

16. Clinical uses of epinephrine Systmatic uses: Cardiac arrest Anaphylactic shock Acute bronchial asthma Topical uses: Adjuvant of local anesthesia Bleeding

17. §1.3 Adverse effects §(1) Cardiac arrhythmia: BP , arrhythmia §(2) Excesive rise of BP: cerebral or subarachnoid hemorrhage §(3) Central excitation ： anxiety §(4) Contraindications: heart diseases, hypertension, coronary arterial disease, arteriosclerosis, hyperthyroidism 1. ,  receptor agonists

18. Ephedrine 麻黄碱 Ephedrine麻黄碱 Epinephrine肾上腺素 1. ,  receptor agonists

19. §1.1 Pharmacological effects §Promoting release of NE, weak agonist effectson  1 、  2 、  1 、  2 receptors §Promoting release of NE, weak agonist effects on  1 、  2 、  1 、  2 receptors §Properties ： § chemically stable, orally effective ； § less potent and longer action duration; § central stimulating ； § tachyphylaxis. 1. ,  receptor agonists

20. §1.2 Clinical uses §(1) Prevention of hypotension: anesthetics §(2) Nasal decongestion: nasal drop §(3) Bronchial asthma: mild, chronic cases §(4) Relieving allergic disorders: urticaria, angioneurotic edema 1. ,  receptor agonists

21. §1.3 Adverse effects §(1) Central stimulation §(2) CVS effects §(3) Dependence 1. ,  receptor agonists

22. Dopamine 多巴胺 1. ,  receptor agonists

23. §1.1 Pharmacological effects §(1) Cardiac effects ：  1 receptor, weak §(2) Vascular effects and blood pressure ： § DA receptor ： dilatation of renal and mesenteric arteries, blood flow  (small doses); §  1 receptor ： vasoconstriction of skin, mesenteric vessels (larger doses) §(3) Renal effects ： renal vasodilatation; natriuretic effects 1. ,  receptor agonists

24. VasodilatationVasoconstriction Effects of dopamine on CVS

25. §1.2 Clinical uses §(1) Shock §cardiac and septic shock: low output, urinary volume , fully adequate replacement of intravascular fluid §(2) Acute renal failure § combined with furosemide §1.3 Adverse effects § tachycardia, arrhythmia, renal vasoconstriction 1. ,  receptor agonists

26. 2.  receptor agonists § 2-1  1,  2 receptor agonists Norepinephrine 去甲肾上腺素, noradrenaline noradrenaline

27. 2.  receptor agonists §2.1 Pharmacological effects §(1) Vascular effects ： §  1 ： vasoconstriction (skin, renal, brain, hepatic, mesenteric, etc.) § vasodilatation of coronary arteries  2 ： inhibiting NE release §  2 ： inhibiting NE release

28. §(2) Cardiac effects ： weak direct stimulation (  1 ); § weak direct stimulation (  1 ); § inhibition via reflex §(3) Blood pressure ： § SP , DP  (especially at larger doses), larger doses:pulse pressure , blood flow  § larger doses: pulse pressure , blood flow  2.  receptor agonists

29. Actions of norepinephrine on post-synaptic (  1 ) and pre-synaptic (  2 ) receptors

30. §2.2 Clinical uses §(1) Shock § BP , blood flow , tissue damage  § used in early phase of some types of shock or BP rise too slow after treatment: small doses and shorter duration 2.  receptor agonists

31. §(2) Hypotension due to drug poisoning § especially for chlorpromazine §(3) Hemorrhage in upper alimentary tract § orally given after dilution 2.  receptor agonists

32. §2.3 Adverse effects §(1) Ischemia and necrosis at the site of iv administration relieved by filtration with procaine or phentolamine §(2) Acute renal failure avoiding larger doses and longer duration; monitoring urinary volume §(3) Contraindication hypertension, arteriosclerosis, heart diseases, severe urinary volume , microcirculation disorders 2.  receptor agonists

33. §Acting on  receptors directly, promoting NE release indirectly ； §Weaker effects and longer duration than NE, §weak for renal vessels; §Used in early phase of shock, hypotension Metaraminol 间羟胺, Aramine 2.  receptor agonists

34.  2-2  1 receptor agonists § §used in hypotension, paroxysmal supraventricular tachycardia (by reflex) ； §Mydriasis (phenylephrine): pupillary dilator muscles, no or less effect on intraocular pressure, short-acting (for several hours) Phenylephrine 去氧肾上腺素 Phenylephrine 去氧肾上腺素 Methoxamien 甲氧明 Methoxamien 甲氧明 2.  receptor agonists

35. 3.  receptor agonists §3-1  1,  2 receptor agonists Isoproterenol 异丙肾上腺素, Isoprenaline Isoprenaline

36. 3.  receptor agonists §3.1 Pharmacological effects §(1) Cardiac effects §  1 receptor stimulation §(2) Vascular effects and blood pressure §  2 receptor: dilatation of skeletal muscles and coronary vessels ； § SP  ， DP  or  ， pulse pressure 

37. §(3) Bronchodilatation §  2 receptor ， no effect on edema of mucosa §(4) Metabolism § Promoting effects as epinephrine 3.  receptor agonists

38. Effects of isoproterenol

39. 3.2 Clinical uses §(1) Cardiac arrest §(2) A-V block §(3) Septic shock ： low-output §(4) Bronchial asthma ： § usually  2 receptor agonists 3.  receptor agonists

40. 3.3 Adverse effects §(1) Heart stimulation, arrtythmia §(2) Contraindications: § coronary heart disease, myocarditis, hyperthyroidism 3.  receptor agonists

41. §3-2  1 receptor agonists §Heart failure §Cardiac stimulation Dobutamine 多巴酚丁胺 3.  receptor agonists

42. §3-3  2 receptor agonists Bronchial asthma § Bronchial asthma Salbutemol 沙丁胺醇 3.  receptor agonists